Altitude-Specific IOP Risks After Vitrectomy With Gas Tamponade: Modeling and Travel Guidance Based on Calculated Elevation Profiles

Purpose

To develop a globally applicable, theoretical mathematical construct for predicting altitude-related intraocular pressure (IOP) elevation following pars plana vitrectomy (PPV) with intraocular gas tamponade, enabling personalized travel risk assessment through route-specific elevation profiling and bedside computational tools.

Design

Single-center retrospective observational case series integrated with computational modeling and clinical illustrative scenarios.

Subjects

Twelve patients (12 eyes) who underwent standard PPV with 14% C₃F₈ tamponade at Xinhua Hospital (altitude 0 m), failed to follow postoperative travel restrictions, and subsequently developed symptomatic IOP elevation during high-altitude travel (≥1000 m).

Methods

A mathematical model was developed integrating Boyle-Mariotte’s law with first-order gas absorption kinetics, incorporating surgical center altitude correction. Clinical application employs a binary safety threshold (ΔIOP ≤6 mm Hg: proceed; >6 mm Hg: defer). The framework was applied to 4 gases (14% C₃F₈, 16% C₂F₆, 20% SF₆, and 100% air). A Google Earth Pro-based elevation profiling protocol and web-based calculator were developed for bedside risk estimation.

Main Outcome Measures

Predicted ΔIOP, binary safety determination, and minimum safe air travel intervals by gas type.

Results

Theoretical safety intervals varied by half-life: air travel (2400 m cabin) was safe after day 35 for C₃F₈, day 22 for both SF₆ and C₂F₆, and day 13 for air. The 12 cases illustrated clinical utility.

Conclusions

This theoretical construct provides a reproducible, globally applicable binary decision-support tool for post-vitrectomy travel risk assessment. Route-specific elevation profiling and web-based calculation enable personalized bedside risk estimation.

INTRODUCTION

P ars plana vitrectomy (PPV) with intraocular gas tamponade has become a cornerstone in managing retinal detachment, macular holes, and vitreous hemorrhage. Inert expansile gases such as perfluoropropane (C₃F₈), sulfur hexafluoride (SF₆) and perfluoroethane (C₂F₆), owing to their high surface tension and insolubility in water, significantly enhance retinal reattachment rates. However, their postoperative volume fluctuations under the dual influence of time and altitude also render elevated intraocular pressure (IOP)-induced glaucoma one of the most frequent complications. Studies ,,,, report that postoperative IOP elevation occurs in 18%-59% of C₃F₈-filled eyes. Once IOP exceeds 24 mm Hg or increases by ≥ 10 mm Hg from baseline, patients may develop acute ocular pain, vision loss, headache, and nausea. Delayed intervention can rapidly lead to irreversible optic nerve atrophy or even blindness.

Previous studies have confirmed that gas-induced pupillary block, angle closure, trabecular meshwork obstruction, and aqueous humor production-outflow imbalance constitute the primary pathophysiological mechanisms of postoperative IOP elevation. However, clinically actionable “safe travel” thresholds remain lacking. Although international researchers have proposed single-factor IOP prediction models ,,,, , these only account for either time or altitude in isolation, yielding vague recommendations such as “delay air travel whenever possible” or “avoid high-altitude regions.” Such guidance proves impractical given global topographic diversity—from sea-level coastal cities to high-altitude plateaus—and the complexity of modern multimodal transportation networks.

To address this gap, this study establishes a simplified mathematical theoretical construct that integrates dual time-altitude variables based on Boyle’s law coupled with first-order gas absorption kinetics. Computational modeling (Matlab) generates quantitative safety boundaries for postoperative travel based on predicted IOP elevations. To enable personalized route assessment, we developed a standardized protocol utilizing Google Earth Pro for elevation profiling and a web-based calculator for clinical risk prediction. Twelve retrospective cases of postoperative IOP elevation following high-altitude exposure are presented to illustrate the potential utility and clinical helpfulness of this theoretical framework. This framework proposes a quantitative decision-making protocol for consideration in clinical practice, pending individualized patient assessment.

MATERIALS AND METHODS

This single-center retrospective observational case series was conducted at the Department of Ophthalmology, Xinhua Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China. This study was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (XHEC- d -2026-018). As a retrospective chart review without prospective intervention, this study was exempt from clinical trial registration requirements.

Inclusion and Exclusion Criteria

This single-center retrospective observational study consecutively enrolled 12 patients (12 eyes) who:

  • (1)

    Underwent standard 25-gauge PPV with 4.5 mL of 14% C₃F₈ tamponade at Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (January 2008–August 2025);

  • (2)

    Failed to follow post-operative clinical instructions and traveled to high-altitude areas before complete absorption of the intraocular gas.

  • (3)

    Developed symptomatic IOP elevation accompanied by IOP-related symptoms (ocular pain, headache, acute vision loss, or nausea/vomiting) within 60 days postoperatively during travel to altitudes ≥ 1000 m;

  • (4)

    Provided complete clinical and follow-up data.

The study protocol received approval from the institutional ethics committee, with written informed consent obtained from all participants.

Exclusion Criteria:

  • (1)

    Preoperative glaucoma or baseline IOP > 21 mm Hg;

  • (2)

    Concurrent ocular trauma or scleral buckling;

  • (3)

    Insufficient follow-up (<3 months).

In this study, the term “sex” refers to the biological attribute based on physical and physiological characteristics (male/female), as recorded in the medical records. The term “gender” (referring to social identity) was not assessed, as the analysis focused on biological parameters affecting intraocular pressure dynamics.

KEY VARIABLES

  • (1)

    Postoperative Exposure Interval Defined as the duration (days) from surgery to first high-altitude exposure.

  • (2)

    Visual Acuity (VA) Assessment

  • a) Deterioration: Increase in logMAR ≥ 0.2 (≥2 lines on Snellen chart);

  • b) Improvement: Decrease in logMAR ≥ 0.2;

  • c) Stability: logMAR change within ± 0.2;

  • d) For patients with non-quantitative visual acuity recordings, visual deterioration is defined by meeting any of the following criteria:

  • 1) Reduction in counting fingers (CF) distance by ≥ 50% (e.g., CF/50 cm → CF/25 cm)

  • 2) Worsening of visual acuity grade: CF → Hand motion (HM), HM → Light perception (LP), LP → No light perception (NLP)

Mixed Gas Expansion Model

Assumptions

  • 1)

    Total intraocular gas volume = 4.5 mL (adult average );

  • 2)

    Gas composition varies by tamponade agent (see Table 1 for specific parameters);

    Table 1

    Gas-Specific Parameters for Mathematical Modeling.

    Gas Isovolumetric % V gas (0)(ml) V air (0)(ml) t 1/2 (days)
    C 3 F 8 14% 0.63 3.87 10
    C 2 F 6 16% 0.72 3.78 6
    SF 6 20% 0.90 3.60 5.5
    Air – 0 4.50 2

    Abbreviations: V gas (0)(ml) = initial expansile gas volume;V air (0)(ml) =initial air volume; t 1/2 (days) =elimination half-life.

  • 3)

    All gases obey Boyle-Mariotte’s law with first-order absorption kinetics;

  • 4)

    Ocular compliance (C) = 3.115 µL/mm Hg 9.

Residual Gas Volume

The intraocular gas volume at postoperative day t is calculated as:

V ( t ) = V gas ( 0 ) · e − k gas · t + V air ( 0 ) · e − k air · t

Parameters:

  • •

    V gas ( 0 ) , V air ( 0 ) : Initial volumes of expansile gas and air (mL)

  • •

    k : Gas elimination rate constant (day⁻¹)

Kinetic Note:

The rate constant k = ln ⁡ ( 2 ) t 1 / 2 derives from first-order absorption kinetics, where t 1 / 2 is the gas-specific half-life. Table 1 lists the half-lives for all gases.

Pressure-Altitude Function

Based on ICAO standard atmosphere :

P ( h ) = 760 ( 1 − 0.0065 h 288.15 ) 5.2561
where h = altitude (meters), P(h) = atmospheric pressure (mm Hg).

IOP Elevation Calculation

Δ IOP = Δ I O P ( t , h , h 0 ) = 1 C · [ V g a s · e − k g a s t + V a i r · e − k a i r t ] · ( P ( h 0 ) P ( h m a x ) − 1 )
where h 0 = altitude of surgical center (meters), P ( h 0 ) = atmospheric pressure at surgical center (mm Hg). h max = maximal route altitude (meters), P ( h max )= atmospheric pressure at the maximal route altitude (mm Hg). For sea-level surgical centers (e.g., Shanghai, New York), h 0 = 0 m and P ( h 0 ) =760 mm Hg.

Aircraft Cabin Pressure Adjustment

Steady-state cabin pressure was modeled as 2400 m equivalent altitude.

Statistical Analysis

Continuous variables were tested for normality using Shapiro-Wilk test. Normally distributed data were expressed as mean ± SD; non-normal data as median (IQR). Categorical variables were reported as frequency (%). Analyses used IBM SPSS 26.0, with 2-sided P <.05 deemed significant. The 12 cases were subsequently input into the theoretical model to calculate predicted ΔIOP values for illustrative demonstration of clinical utility.

RESULTS

Baseline Characteristics

This study included 12 patients (12 eyes) who developed elevated intraocular pressure following early postoperative high-altitude exposure. The median age was 31.0 years (IQR 16.5-51.5), with male sex predominance (9 cases, 75.0%). Left eye involvement occurred in 6 cases (50.0%). The primary diagnoses included retinal detachment (7 eyes, 58.3%), macular hole (4 eyes, 33.3%) and proliferative diabetic retinopathy with vitreous hemorrhage (1 eye, 8.3%).

Preoperative intraocular pressure measured 15.5 mm Hg (IQR 14.3-17.8), increasing to 17.5 mm Hg (IQR 15.0-20.3) on postoperative day 1. The median interval from surgery to intraocular pressure elevation (>21 mm Hg) was 21 days (IQR 10.5-28.0). Patients traveled to median altitudes of 1500 m (IQR 1125-2400), with 8 cases (66.7%) using high-speed rail and 4 cases (33.3%) traveling by air.

Presenting symptoms included ocular distension/pain (9 cases), headache (5 cases), acute vision loss (2 cases). Visual acuity changes assessed by logMAR criteria showed deterioration ≥ 0.2 in 6 eyes (50.0%), improvement in 3 eyes (25.0%), and stability in 3 eyes (25.0%). Two cases progressed to no light perception (logMAR 3.0), indicating end-stage visual impairment. Detailed data are presented in Table 2 .

Table 2

Clinical Characteristics and Outcome Analysis of Patients with Postoperative Intraocular Pressure Elevation Following High-Altitude Exposure.

ID Sex Age Eye Diagnosis Surgery Transport Altitude (m) Symptoms Pre-op IOP (mm Hg) POD1 IOP (mm Hg) Post-op IOP (mm Hg) Time to IOP Spike (days) Pre-op VA Post-op VA Pre-op logMAR Post-IOP logMAR Change Predicted ΔIOP Risk Zone
1 M 77 OD RD, Macular Schisis, PM phaco + IOL + PPV + C3F8 Airplane 2400 Eye pain Tn 22 15 32 FC/BE HM/BE – – Decrease 7.4857 Red
2 M 16 OS RD, SO Eye, FEVR SO Removal + PPV + C3F8 Train 1500 Headache 18 15 12 8 FC/30cm FC/BE – – Decrease 38.4376 Red
3 M 36 OS Ocular Trauma, RD, Cataract PPV + Lensectomy + FB Removal + C3F8 HSR 3000 Headache Tn 15 19 28 FC/BE FC/30cm – – Improve 12.9648 Red
4 F 20 OD RD, FEVR PPV + Membrane Peeling + PR + C3F8 HSR 1100 Eye pain 14 21 20 23 FC/50cm NLP – – Decrease 5.8589 Green
5 M 46 OD MH, Post-RK PPV + ILM Plug + C3F8 HSR 1500 Eye pain, Headache 21 18 14 5 0.04 0.04 1.4 1.4 Stable 71.9202 Red
6 M 18 OS RD, FEVR PPV + PR + C3F8 Airplane 2400 Eye pain 14 18 19 30 0.1 FC/50cm 1 – Decrease 8.6043 Red
7 M 47 OD MH PPV + ILM Plug + C3F8 HSR 1100 Headache 17 17 21 5 HM/BE NLP – – Decrease 51.1985 Red
8 F 26 OD RD PPV + PR + C3F8 HSR 1500 Eye pain 16 18 15 28 0.1 0.15 1 0.8 Improve 5.7745 Green
9 M 6 OD Traumatic MH, RD PPV + ILM Plug + C3F8 HSR 1100 Headache, Eye pain, Vomiting 13 15 9 21 0.1 LP 1 2.7 Decrease 6.7817 Red
10 M 6 OS Traumatic MH PPV + ILM Peeling + C3F8 HSR 1200 Eye pain 19 21 20 20 0.1 0.1 1 1 Stable 8.0335 Red
11 F 53 OS PDR, VH, Cataract phaco + IOL + PPV + C3F8 Airplane 2400 Eye pain, Sudden VA loss Tn 15 21 21 0.1 0.4 1 0.4 Improve 16.3238 Red
12 M 68 OS MH phaco + IOL + PPV + C3F8 Airplane 2400 Eye pain, Sudden VA loss 16 15 14 18 0.25 0.25 0.6 0.6 Stable 20.5626 Red
Only gold members can continue reading. Log In or Register to continue

Related posts:

  1. The Multimodal Imaging in Uveitis Virtual Special Issue
  2. Unsuccessful Clinical Trials in Retina: Lessons Learned
  3. Vitamin B Intake Is Associated With Lower Incidence of Open-Angle Glaucoma: The Rotterdam Study
  4. Auto Machine Learning for Diabetic Retinopathy Screening: A Head-to-Head Multiplatform Comparison Against Human Graders and IDx-DR

Stay updated, free articles. Join our Telegram channel
Tags:
Sep 20, 2026 | Posted by in OPHTHALMOLOGY | Comments Off on Altitude-Specific IOP Risks After Vitrectomy With Gas Tamponade: Modeling and Travel Guidance Based on Calculated Elevation Profiles

Full access? Get Clinical Tree
Get Clinical Tree app for offline access